C-reactive protein for discriminating treatment failure from slow responding pneumonia

European Journal of Internal Medicine

Volumn 21, Issue 6, 2010, Pages 548-552

  Ruiz González, Agustín ^a   Falguera, Miquel ^a   Porcel, José Manuel ^a   Martínez Alonso, Montserrat ^a   Cabezas, Pamela ^a   Geijo, Paloma ^b   Boixeda, Ramón ^c   Dueñas, Carlos ^d   Armengou, Arola ^e   Capdevila, Josep Antoni ^c   Serrano, Regino ^f  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^b HOSPITAL VIRGEN DE LA LUZ   (Spain)

^c Critical Care Unit   (Spain)

^d HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^e HOSPITAL JOSEP TRUETA   (Spain)

^f HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

C reactive protein; Community acquired; Pneumonia; Treatment failure

Indexed keywords

BETA LACTAM; C REACTIVE PROTEIN; MACROLIDE; QUINOLONE;

ADULT; AGED; ARTICLE; BREATHING RATE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; MULTICENTER STUDY; PHYSICIAN; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; TREATMENT RESPONSE;

AGED; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY-ACQUIRED INFECTIONS; COXIELLA BURNETII; DRUG MONITORING; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, BACTERIAL; PNEUMONIA, MYCOPLASMA; Q FEVER; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE;

EID: 78649524557     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.09.006     Document Type: Article

References (21)

1. M.S. Niederman, J.I. McCombs, A.N. Unger, A. Kumar, and R. Popovian The cost of treating community-acquired pneumonia Clin Ther 20 1998 820 837
2. F. Arancibia, S. Ewig, and J.A. Martínez Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications Am J Respir Crit Care Med 162 2000 154 160
3. B. Rosón, J. Carratalá, N. Fernández-Sabé, F. Tubau, F. Manresa, and F. Gudiol Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia Arch Intern Med 164 2004 502 508
4. R. Menéndez, A. Torres, and F. Rodríguez de Castro Risk factors of treatment failure in community-acquired pneumonia: implications for diseases outcome Thorax 59 2004 960 965
5. D. Genné, R. Sommer, and L. Kaiser Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia Eur J Clin Microbiol Infect Dis 25 2006 159 166
6. L.A. Mandell, R.G. Wunderink, and A. Anzueto Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infec Dis 44 2007 S27 S72
7. M.S. Finkelstein, W.M. Petkun, M.L. Freedman, and S.C. Antopol Pneumococcal bacteremia in adults: age-dependent differences in presentation and in outcome J Am Geriatr Soc 31 1983 19 37
8. K. Lehtomaki Clinical diagnosis of pneumococcal, adenoviral, mycoplasmal and mixed pneumonias in young men Eur Respir J 1 1988 324 329
9. E.A. Halm, M.J. Fine, and T.J. Marrie Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines JAMA 279 1998 1452 1457
10. J.A. Ramírez, and J. Bordon Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia Arch Intern Med 1999 2449 2454
11. P. Póvoa, L. Coelho, and E. Almeida C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study Eur Respir J 25 2005 804 812
12. Macfarlane JT, Boswell T, Douglas G, et al. BTS guidelines of the management of community-acquired pneumonia in adults - 2004 update. Available at http://www.brit-thoracic.org/guidelines. Accessed April 1, 2009.
13. M.J. Fine, T.E. Auble, and D.M. Yealy A prediction rule to identify low-risk patients with community-acquired pneumonia N Eng J Med 336 1997 243 250
14. L. Alfageme, J. Aspa, and S. Bello Normativas para el diagnóstico y el tratamiento de la neumonía adquirida en la comunidad. Sociedad Española de neumología y Cirugía Torácica (SEPAR) Arch Bronconeumol 41 2005 272 289
15. S.A. Flanders, J. Stein, G. Shochat, K. Sellers, M. Holland, and Maselli Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough Am J Med 116 2004 529 535
16. A. Castro-Guardiola, A. Armengou-Arxé, and A.L. Viejo-Rodriguez Differential diagnosis between community-acquired pneumonia and non pneumonia diseases of the chest in the emergency ward Eur J Intern Med 11 2000 334 339
17. L.O. Hansson, J.U. Hedlund, and A.B. Ortqvist Sequential changes of inflammatory and nutritional markers in patients with community-acquired pneumonia Scand J Clin Lab Invest 57 1997 111 118
18. J.D. Chalmers, A. Singanayagam, and A.T. Hill C-reactive protein is an independent predictor of severity in community-acquired pneumonia Am J Med 121 2008 219 225
19. R. Menéndez, M. Cavalcanti, and R. Reyes Markers of treatment failure in hospitalised community acquired pneumonia Thorax 63 2008 447 452
20. A.H. Bruns, J.J. Oosterheert, E. Hak, and A.I. Hoepelman Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia Eur Respir J 32 2008 726 732
21. R. Menéndez, A. Torres, and F. Rodríguez de Castro Reaching stability in commuity-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients Clin Infect Dis 39 2004 1783 1790